These Robots Could Be Headed To The Operating Room Soon
Monogram aims to revolutionize the $19.4B knee replacement industry by developing precision surgical robotics to install personalized, 3D printed implants.
And you can invest in the company ahead of their planned Nasdaq listing.
With 100,000 failed joint replacement surgeries every year, we believe that this market has been due for a realignment. Surgeons have been forced to rely on the same technology, like hand saws and generic-sized joint implants for the last 40 years.
Monogram has already demonstrated how their surgical system works on cadavers in front of 5,000+ live viewers, they have 20 patents filed, and 17,000+ people have previously invested...
Join Monogram ahead of their intended NASDAQ listing. Opportunity ends 5/10.
Invest Now